𝔖 Bobbio Scriptorium

✦ LIBER ✦

US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids

✍ Scribed by Dr Sebastiano Mercadante, David Craig, Antonello Giarratano

Book ID: 119931530
Publisher: Springer International Publishing AG
Year: 2012
Tongue: English
Weight: 119 KB
Volume: 72
Category: Article
ISSN: 0012-6667
DOI: 10.2165/11642230-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The US Food and Drug Administration's Ri

The US Food and Drug Administration's Risk Evaluation and Mitigation Strategy (REMS) Program in Practice: Does It Really Inform Patients and Limit Risk?

✍ Robert A. Cohen; Robert S. Brown 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 165 KB

The US Food and Drug Administration and

The US Food and Drug Administration and long-acting β2-agonists: The importance of striking the right balance between risks and benefits of therapy?

✍ Lemanske, Robert F.; Busse, William W. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 72 KB

PRS40 THE IMPACT OF THE FDA'S RISK EVALU

PRS40 THE IMPACT OF THE FDA'S RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS

✍ Horowicz-Mehler, N; Sepulveda, B; White, C; Doyle, J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Comparative evaluation of etest for susc

Comparative evaluation of etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents An investigation using U.S. food and drug administration regulatory criteria

✍ Steven A. Marshall; Paul R. Rhomberg; Ronald N. Jones 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 623 KB

Preclinical development of biological re

Preclinical development of biological response modifiers intended for use in the treatment of HIV infection and associated disorders : S. L. Lard, M. A. Ussery, & J. C. Ramsey, Division of Antiviral Drug Products (HFD-530), Center For Drug Evaluation and Research, U.S. Food & Drug Administration, 5600 Fishers Lane Rockville, MD, U.S.A. 20857

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Preparation of a monoclonal antibody to

Preparation of a monoclonal antibody to a hemorrhagic toxin from Prairie rattlesnake (Crotalus viridis viridis) venom: its characteristics and use in isolating the toxin: Charlotte L. Ownby,1Jane Halpern,2 and William H. Habig2 (1Department of Physiological Sciences, Oklahoma State University, Stillwater, OK 74078, U.S.A., and 2Center for Biologics Evaluation and Research, Laboratory of Bacterial Toxins, Division of Bacterial Products, U.S. Food and Drug Administration, Bethesda, MD, U.S.A.)

📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 189 KB